HR Execs on the Move

Intervala

www.intervala.com

 
Full-service manufacturer. Innovative problem solver. Customer satisfaction champion. At Intervala, we believe there`s a solution to every problem. We create customized, intelligent solutions for each customer`s unique electronic and electromechanical product requirements. Total customer satisfaction is the cornerstone of our business. Intervala is a full-service manufacturer of high-reliability, precision electronic and electromechanical products for companies in industrial, medical, transportation, and other technology-driven markets. Customers choose us because we understand their complex product and service needs. Our team draws on decades of experience to bring a fresh approach to problem-solving, combining turnkey manufacturing capabilities and engineering, materials management, and global fulfillment ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.intervala.com
  • 700 Braddock Avenue
    East Pittsburgh, PA USA 15112
  • Phone: 412.829.4807

Executives

Name Title Contact Details
Matt McDaniel
Chief Financial Officer Profile

Similar Companies

Ohio Valley Door Corp

Ohio Valley Door Corp is a New Albany, IN-based company in the Manufacturing sector.

Giles Enterprises Inc

Giles Enterprises Inc is a Montgomery, AL-based company in the Manufacturing sector.

Electro-Coatings Of California

Electro-Coatings Of California is a Berkeley, CA-based company in the Manufacturing sector.

Winneram International Inc

Winneram International Inc is a South El Monte, CA-based company in the Manufacturing sector.

Neos Therapeutics

Neos Therapeutics is focused on developing, manufacturing and commercializing branded products utilizing our proprietary extended-release drug delivery technology platform, which serves as the basis for our three product candidates being investigated for the treatment of attention deficit hyperactivity disorder (ADHD). Our ADHD product candidates include the following formulations; oral disintegrating tablets (ODT) and liquid suspension. Drug Delivery Platform: Our proprietary extended-release drug delivery platform has enabled us to create new patient- and caregiver-friendly dosage forms of methylphenidate and amphetamine. Formulations: In 2014 alone, 63.1 million prescriptions for medications with ADHD labeling, and principally in extended-release formulations, were written in the United States. The majority of currently available dosage forms for ADHD are tablets and capsules. The two lead Neos Therapeutics product candidates provide a plasma concentration-time profile that is consistent with once daily dosing in an orally disintegrating tablet that disintegrates in the mouth without water. Our goal is to be a leading pharmaceutical company focused on the development, manufacture and commercialization of branded pharmaceutical products that utilize our proprietary extended-release drug delivery technology platform. Neos Therapeutics is a growing, dynamic company that can provide employees with the opportunities and challenges they need to enjoy a rewarding career and make a difference in the lives of others. Our success depends on a motivated team of people collaborating to create quality healthcare products. This requires employees with exceptional leadership skills, flexibility, technical expertise and a commitment to excellence. We offer competitive compensation packages to full-time employees. We seek to attract the right people and provide incentives and career development that can turn employment into opportunity.